A.8 CD-19-directed CAR-T cell therapy - relapsed/refractory large B-cell lymphoma - EML

Application, expert reviews and public comments

Application

Inclusion of CD-19-directed CAR-T cell therapy - relapsed/refractory large B-cell lymphoma - EML

Expert reviews

Expert Review 1

Expert Review 2

Expert Review 3

Comments

International Society of Oncology Pharmacy Practitioners

EML Working Groups

EML Cancer Medicines Working Group

WHO Department Comments

Noncommunicable Diseases